Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche snags another Perjeta combo nod, but will 'weak' data limit its use?
Fierce Pharma
Thu, 12/28/17 - 11:15 am
Tags:
Roche, Perjeta, breast cancer
Oncology business to keep leading pharma market in 2018
GoinPharma
Wed, 12/27/17 - 09:39 am
Tags:
oncology, Merck, Bristol-Myers Squibb, Pfizer, Roche
Roche’s and Bayer’s strategies compared
GoinPharma
Tue, 12/26/17 - 09:39 am
Tags:
Roche, Bayer
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Sat, 12/23/17 - 11:39 pm
Tags:
biotech, Ignyta, Roche, M&A, Molecular Templates, Biohaven Pharmaceuticals, trigriluzole
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal
Xconomy
Fri, 12/22/17 - 09:51 am
Tags:
Roche, Ignyta, M&A, precision medicine, oncology
Shire looks to stall Hemlibra impact with court injunction
BioPharma Dive
Tue, 12/19/17 - 12:03 pm
Tags:
Shire, Hemlibra, Roche, hemophilia
Roche snaps up Huntington's drug on positive data
BioPharma Dive
Thu, 12/14/17 - 09:14 am
Tags:
Roche, Huntington's disease, Ionis Pharmaceuticals, IONIS-HTTRx
ASH 2017: What you missed
BioPharma Dive
Wed, 12/13/17 - 06:35 pm
Tags:
ASH17, Biomarin, Spark Therapeutics, Gilead Sciences, Novartis, Juno Therapeutics, AbbVie, Roche, JNJ
AbbVie Makes Progress on Quest to Diversify
Motley Fool
Tue, 12/12/17 - 10:40 pm
Tags:
AbbVie, biosimilars, Roche, Venclexta
Phase 2 data for Roche’s lymphoma ADC doesn’t disappoint
Fierce Biotech
Tue, 12/12/17 - 10:10 am
Tags:
Roche, ASH17, clinical trials, non-Hodgkin's lymphoma, antibody-drug conjugate
Roche's Fight With Pfizer May Be Just The Beginning
Forbes
Mon, 12/11/17 - 11:31 pm
Tags:
Roche, Pfizer, Herceptin, biosimilars, cancer, Avastin, Rituxan
Roche study finds cancer 'Velcro' that halts T-cell attack
Reuters
Sun, 12/10/17 - 09:51 am
Tags:
Roche, T-cells, cancer, drug development
Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst
Fierce Pharma
Sat, 12/9/17 - 02:22 pm
Tags:
Roche, Tecentriq, lung cancer
Roche, Novartis' Italian heads risk trial for alleged market rigging: sources
Yahoo/Reuters
Fri, 12/8/17 - 10:00 am
Tags:
Roche, Novartis, Italy, Avastin, Lucentis, marketing manipulation
Roche's Tecentriq combo cuts risk of lung cancer progression
BioPharma Dive
Thu, 12/7/17 - 11:44 pm
Tags:
Roche, Tecentriq, lung cancer
Most Impressive Drug Launch: Roche's Ocrevus
BioPharma Dive
Mon, 12/4/17 - 11:41 am
Tags:
Roche, Ocrevus, drug launches, MS, multiple sclerosis
#ASH17: Late breaker from AbbVie, Roche highlights a blockbuster breakout opportunity for Venclexta in CLL
Endpoints
Fri, 11/24/17 - 09:25 am
Tags:
ASH, AbbVie, Roche, Venclexta, CLL, chronic lymphocytic leukemia
With $2.5B in Herceptin sales on the line, Roche sues Pfizer for biosim patent infringement
Fierce Pharma
Tue, 11/21/17 - 12:14 pm
Tags:
Herceptin, Roche, Pfizer, biosimilars, breast cancer
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Xconomy
Mon, 11/20/17 - 09:40 am
Tags:
Roche, lung cancer, Genentech, Tecentriq
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
Tags:
cancer, labeling, AstraZeneca, Faslodex, Pfizer, Sutent, kidney cancer, Roche, Gazyva, follicular lymphoma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.